Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: Biochemical probes for analysis and modulation of immune responses

被引:40
|
作者
Lebowitz, MS
O'Herrin, SM
Hamad, ARA
Fahmy, T
Marguet, D
Barnes, NC
Pardoll, D
Bieler, JG
Schneck, JP
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21205 USA
关键词
D O I
10.1006/cimm.1999.1441
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T cell receptors (TCR) and major histocompatibility complex (MHC) molecules are integral membrane proteins that have central roles in cell-mediated immune recognition. Therefore, soluble analogs of these molecules would be useful for analyzing and possibly modulating antigen-specific immune responses. However, due to the intrinsic low-affinity and inherent solubility problems, it has been difficult to produce soluble high-affinity analogs of TCR and class II MHC molecules. This report describes a general approach which solves this intrinsic low-affinity by constructing soluble divalent analogs using IgG as a molecular scaffold. The divalent nature of the complexes increases the avidity of the chimeric molecules for cognate ligands. The generality of this approach was studied by making soluble divalent analogs of two different classes of proteins, a TCR (2C TCR(2)Ig) and a class II MHC (I-MCC. E-k (2)Ig) molecule, Direct flow cytometry assays demonstrate that the divalent 2C TCR(2)Ig chimera retained the specificity of the native 2C TCR, while displaying increased avidity for cognate peptide/MHC ligands, resulting in a high-affinity probe capable of detecting interactions that heretofore have only been detected using surface plasmon resonance. TCR(2)IgG was also used in immunofluorescence studies to show ER localization of intracellular peptide-MHC complexes after peptide feeding. I-MCC-E-k (2)Ig chimeras were able to both stain and activate an MCC-specific T cell hybridoma. Construction and expression of these two diverse heterodimers demonstrate the generality of this approach. Furthermore, the increased avidity of these soluble divalent proteins makes these chimeric molecules potentially useful in clinical settings for probing and modulating In vivo cellular responses. (C) 1999 Academic Press.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 44 条
  • [21] Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses
    Elbe-Bürger, A
    Mommaas, AM
    Prieschl, EE
    Fiebiger, E
    Baumruker, T
    Stingl, G
    IMMUNOLOGY, 2000, 101 (02) : 242 - 253
  • [22] CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION OF HUMAN T-CELL RESPONSES TO SHORT RAGWEED ALLERGEN, AMB-A-V
    HUANG, SK
    ZWOLLO, P
    MARSH, DG
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (06) : 1469 - 1473
  • [23] Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry
    Sami, Malkit
    Rizkallah, Pierre J.
    Dunn, Steve
    Molloy, Peter
    Moysey, Ruth
    Vuidepot, Annelise
    Baston, Emma
    Todorov, Penio
    Li, Yi
    Gao, Feng
    Boulter, Jonathan M.
    Jakobsen, Bent K.
    PROTEIN ENGINEERING DESIGN & SELECTION, 2007, 20 (08): : 397 - 403
  • [24] THE ROLE OF T-CELL SUBSETS IN THE GENERATION OF SECONDARY CYTOLYTIC RESPONSES INVITRO AGAINST CLASS-I AND CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS
    VIDOVIC, D
    KLEIN, J
    NAGY, ZA
    JOURNAL OF IMMUNOLOGY, 1984, 132 (03): : 1113 - 1117
  • [25] INCREASED USAGE OF V-DELTA-4+ T-CELL RECEPTORS BY INTESTINAL INTRAEPITHELIAL LYMPHOCYTES IS REGULATED BY CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX
    LEFRANCOIS, L
    IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) : 334 - 340
  • [26] BINDING OF T-CELL RECEPTOR TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-PEPTIDE COMPLEXES AT THE SINGLE-CELL LEVEL RESULTS IN THE INDUCTION OF ANTIGEN UNRESPONSIVENESS (ANERGY)
    CELIS, E
    SAIBARA, T
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) : 3127 - 3134
  • [27] MODULATION OF ANTIGEN-PROCESSING BY BOUND ANTIBODIES CAN BOOST OR SUPPRESS CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX PRESENTATION OF DIFFERENT T-CELL DETERMINANTS
    SIMITSEK, PD
    CAMPBELL, DG
    LANZAVECCHIA, A
    FAIRWEATHER, N
    WATTS, C
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 1957 - 1963
  • [28] MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTED ANTIGEN RECOGNITION - HIGH-FREQUENCY OF HUMAN T-CELL CLONES RECOGNIZING NOVEL MHC CLASS-II DETERMINANTS
    NISBETBROWN, F
    LEE, JWW
    LETARTE, M
    FALK, JA
    GELFAND, EW
    HUMAN IMMUNOLOGY, 1987, 19 (01) : 41 - 52
  • [29] Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status
    Landahl, Johanna
    Bockmann, Jan Hendrik
    Scheurich, Christoph
    Ackermann, Christin
    Matzat, Verena
    Heide, Janna
    Nuurei, Tungalag
    D'Antonio, Gianluca
    von Felden, Johann
    Sette, Alessandro
    Peine, Sven
    Lohse, Ansgar W.
    Luetgehetmann, Marc
    Marget, Matthias
    Sidney, John
    zur Wiesch, Julian Schulze
    JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (04): : 568 - 577
  • [30] PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II COMPLEXES WITH MIXED AGONIST ANTAGONIST PROPERTIES PROVIDE EVIDENCE FOR LIGAND-RELATED DIFFERENCES IN T-CELL RECEPTOR DEPENDENT INTRACELLULAR SIGNALING
    RACIOPPI, L
    RONCHESE, F
    MATIS, LA
    GERMAIN, RN
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04): : 1047 - 1060